Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,42 USD | +6,61% | +13,62% | +89,06% |
Attività
Numero di dipendenti: 30
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 30/08/19 |
Chief Tech/Sci/R&D Officer | - | 29/11/22 | |
Rekha Garg
LAW | General Counsel | - | 29/11/22 |
Amin Kamel
PRN | Corporate Officer/Principal | - | 02/06/22 |
Daniel Penksa
AUD | Comptroller/Controller/Auditor | 39 | 01/06/15 |
Christopher Aker
LAW | General Counsel | 63 | 19/05/11 |
Brian K. Campion
PRN | Corporate Officer/Principal | - | 01/07/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 01/06/17 |
David Baltimore
BRD | Director/Board Member | 86 | 01/01/09 |
Director/Board Member | 75 | 01/04/13 | |
Chairman | 74 | 01/01/08 | |
Jake Nunn
BRD | Director/Board Member | 54 | 11/06/19 |
Alice S. Huang
BRD | Director/Board Member | 85 | 26/01/21 |
Hugh Rosen
BRD | Director/Board Member | 64 | 02/06/16 |
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Director/Board Member | 56 | 17/04/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 3 725 720 | 0 | 0 | 95,99 % |
Azione B | 0 | 258 707 | 0 | 0 | |
Azione C | 0 | 1 330 832 | 0 | 0 | |
Azione D | 1 | 65 465 251 | 64 363 054 ( 98,32 %) | 0 | |
Azione E | 0 | 256 700 | 0 | 0 |
Coordinate società
Regulus Therapeutics, Inc.
4224 Campus Point Court Suite 210
92121, San Diego
+858 202 6300
http://www.regulusrx.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+89,06% | 158 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,73 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione RGLS
- Società Regulus Therapeutics Inc.